In recent years, consumers' views on health have changed significantly, with an increased focus on preventive health measures and overall well-being. Interest in gut health is growing, driven by greater awareness of the importance of gut health for overall health. This in turn has led to an increase in the demand for probiotics, live bacteria that promote a healthy gut. 

Probi offers high-quality food supplements with lactic acid bacteria, supported by extensive research and clinical studies. The range, which consists of products for various health areas such as gut health, immune health and women's health, contributes to a healthy lifestyle. 

The products are currently sold mainly through pharmacies, both in physical stores and online, in the Swedish, Norwegian and Icelandic markets. Through the collaboration with Matas, the chain's e-commerce customers will initially have access to Probi's range. 

"We are very excited about our collaboration with Matas, and that Probi's scientifically well-documented products are now also available to Danish consumers who want to improve their health and quality of life with lactic acid bacteria" says Anita Johansen, CEO of Probi.

Matas has a long tradition of offering quality health and beauty products and enjoys strong trust among Danish consumers. Matas' e-commerce platform is the second largest in Denmark with a high level of customer satisfaction. 

With this collaboration, Probi AB looks forward to giving Matas' customers the opportunity to experience the benefits of our probiotic supplements. 

For further information, please contact:

Daniel Hovel Hansen, Sales Director EMEA, Probi AB

Tel: +46 709 26 88 53, E-mail: daniel.hovel.hansen@probi.com  

Martina Pettersson, Global Marketing Director, Probi AB

Tel: +46 46 286 89 61 E-mail: martina.pettersson@probi.com

ABOUT PROBI

Probi[®] is a global company focused exclusively on researching, manufacturing, and delivering probiotics for
supplements and functional food. We are experts at managing stable, live bacteria from R&D through every
stage of the manufacturing process and are dedicated to making the health-enhancing benefits of probiotics
available to people everywhere. Our health concepts, formulations, and formats are supported by robust clinical documentation. Since our founding in 1991 at Sweden's Lund University, Probi has expanded its operations to more than 40 markets. We hold more than 400 patents globally. Probi had sales of SEK 628 m in 2023. Probi's shares are listed on Nasdaq Stockholm, Mid-cap, and there were around 3,400 shareholders on December 31, 2023.